相似文献
1
Intratumoral mast cells promote the growth of pancreatic cancer.
Oncoimmunology. 2013 Oct 1;2(10):e25964. doi: 10.4161/onci.25964. Epub 2013 Aug 2.
2
Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.
Cancer Res. 2013 Jul 1;73(13):3927-37. doi: 10.1158/0008-5472.CAN-12-4479. Epub 2013 Apr 30.
3
The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives.
Front Oncol. 2021 Jan 14;10:621937. doi: 10.3389/fonc.2020.621937. eCollection 2020.
4
Pancreatic stellate cells: Aiding and abetting pancreatic cancer progression.
Pancreatology. 2020 Apr;20(3):409-418. doi: 10.1016/j.pan.2020.01.003. Epub 2020 Jan 7.
5
Pancreatic Stellate Cells: The Key Orchestrator of The Pancreatic Tumor Microenvironment.
Adv Exp Med Biol. 2020;1234:57-70. doi: 10.1007/978-3-030-37184-5_5.
6
Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay.
J Cell Sci. 2007 Feb 1;120(Pt 3):512-9. doi: 10.1242/jcs.03347. Epub 2007 Jan 16.
7
Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.
Clin Cancer Res. 2011 Nov 15;17(22):7015-23. doi: 10.1158/1078-0432.CCR-11-0607. Epub 2011 Oct 5.
8
Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.
J Exp Clin Cancer Res. 2019 Mar 6;38(1):114. doi: 10.1186/s13046-019-1118-y.
9
The role of the tumor microenvironment in the progression of pancreatic cancer.
J Surg Res. 2008 Oct;149(2):319-28. doi: 10.1016/j.jss.2007.12.757. Epub 2008 Jan 10.
10
Pancreatic stellate cells: A dynamic player of the intercellular communication in pancreatic cancer.
Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S98-103. doi: 10.1016/j.clinre.2015.05.018. Epub 2015 Jul 16.
引用本文的文献
1
Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer.
iScience. 2024 Sep 30;27(11):111085. doi: 10.1016/j.isci.2024.111085. eCollection 2024 Nov 15.
2
Computational modeling of mast cell tryptase family informs selective inhibitor development.
iScience. 2024 Aug 21;27(9):110739. doi: 10.1016/j.isci.2024.110739. eCollection 2024 Sep 20.
3
Gene Expression Comparison between Alcohol-Exposed versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis.
Medicina (Kaunas). 2023 Apr 30;59(5):872. doi: 10.3390/medicina59050872.
4
The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer.
Front Immunol. 2022 Apr 14;13:850093. doi: 10.3389/fimmu.2022.850093. eCollection 2022.
5
The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8 T Cell-Orientated Therapy.
Biomedicines. 2022 Apr 18;10(4):926. doi: 10.3390/biomedicines10040926.
6
Mast Cells Positive for c-Kit Receptor and Tryptase Correlate with Angiogenesis in Cancerous and Adjacent Normal Pancreatic Tissue.
Cells. 2021 Feb 19;10(2):444. doi: 10.3390/cells10020444.
7
Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.
Gastroenterology. 2020 Jul;159(1):306-319.e12. doi: 10.1053/j.gastro.2020.03.018. Epub 2020 Mar 14.
8
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer.
Cancers (Basel). 2019 Mar 7;11(3):330. doi: 10.3390/cancers11030330.
9
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients.
BMC Cancer. 2018 Mar 21;18(1):313. doi: 10.1186/s12885-018-4220-1.
10
The density of mast cells c-Kit and tryptase correlates with each other and with angiogenesis in pancreatic cancer patients.
Oncotarget. 2017 Jul 31;8(41):70463-70471. doi: 10.18632/oncotarget.19716. eCollection 2017 Sep 19.
本文引用的文献
1
Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.
Cancer Res. 2013 Jul 1;73(13):3927-37. doi: 10.1158/0008-5472.CAN-12-4479. Epub 2013 Apr 30.
2
Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.
Gastroenterology. 2013 Jun;144(6):1230-40. doi: 10.1053/j.gastro.2012.12.042.
3
Cancer statistics, 2013.
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
4
Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.
Clin Cancer Res. 2011 Nov 15;17(22):7015-23. doi: 10.1158/1078-0432.CCR-11-0607. Epub 2011 Oct 5.
5
Hallmarks of cancer: the next generation.
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
6
Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma.
Surgery. 2011 Apr;149(4):576-84. doi: 10.1016/j.surg.2010.10.009. Epub 2010 Dec 16.
7
Stromal biology and therapy in pancreatic cancer.
Gut. 2011 Jun;60(6):861-8. doi: 10.1136/gut.2010.226092. Epub 2010 Oct 21.
8
Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression.
Clin Cancer Res. 2010 Apr 15;16(8):2257-65. doi: 10.1158/1078-0432.CCR-09-1230. Epub 2010 Apr 6.
9
The controversial role of mast cells in tumor growth.
Int Rev Cell Mol Biol. 2009;275:89-131. doi: 10.1016/S1937-6448(09)75004-X.
10
Stromal biology of pancreatic cancer.
J Cell Biochem. 2007 Jul 1;101(4):887-907. doi: 10.1002/jcb.21209.
Zotero 插件